Abstract

Research Article

Dengue Epidemic during COVID-19 Pandemic: Clinical and Molecular Characterization – A Study from Western Rajasthan

Praveen Kumar Rathore, Eshank Gupta and Prabhu Prakash

Published: 01 April, 2025 | Volume 9 - Issue 1 | Pages: 005-009

The concurrent emergence of dengue fever and the COVID-19 pandemic posed significant challenges to India’s healthcare system, particularly in Western Rajasthan, a region characterized by its arid climate and unique socio-demographic conditions. This study aimed to investigate the clinical and molecular characteristics of dengue during the COVID-19 pandemic, focusing on trends, diagnostic challenges, and serotype distribution. 
Conducted at Dr. S.N. Medical College, Jodhpur, in 2021, the study included 550 dengue-positive patients confirmed via rapid diagnostic tests and further analyzed using Dengue NS1 antigen and IgM antibody ELISA. Molecular characterization was performed using RT-PCR for serotyping.
The results revealed a male predominance (72.36%) and a higher incidence in the 21–30-year age group (39.09%). Urban areas accounted for 67.73% of cases, with significant NS1 and IgM positivity (p = 0.042 and p = 0.004, respectively). Most cases (86.91%) were managed outpatient, though IgM positivity was significantly higher among hospitalized patients (19.19%, p < 0.001), indicating severe or prolonged infections. Platelet counts were above 100,000/mm³ in 86.91% of cases, with only 0.37% showing critically low counts (< 20,000/mm³). Seasonal analysis showed a peak in October (n = 325), correlating with post-monsoon vector breeding. Serotyping identified DENV2 as the dominant strain (97.42%), associated with severe dengue manifestations, including Dengue Haemorrhagic Fever (DHF).
The study highlights the dual burden of dengue and COVID-19, emphasizing the need for enhanced vector control, improved diagnostic strategies and public health interventions during overlapping outbreaks. The predominance of DENV2 underscores the importance of serotype-specific surveillance and preparedness to mitigate future dengue epidemics in the region.

Read Full Article HTML DOI: 10.29328/journal.ijcv.1001063 Cite this Article Read Full Article PDF

Keywords:

Dengue; COVID-19; Serotyping; DENV2; Western Rajasthan; Seasonal variation; Thrombocytopenia

References

  1. National Vector Borne Disease Control Programme (NVBDCP), India. Dengue Cases and Deaths in India. 2021. Available from: http://nvbdcp.gov.in
  2. World Health Organization (WHO). Dengue and severe dengue. 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue
  3. Indian Council of Medical Research (ICMR). Challenges in managing dengue during the COVID-19 pandemic in India. Indian J Med Res. 2021;153(5):567-572.
  4. Sharma R, Singh P, Verma K. Coexistence of dengue and COVID-19: A diagnostic challenge in resource-limited settings. J Vector Borne Dis. 2022;59(3):221-228.
  5. Ministry of Health and Family Welfare (MoHFW), Government of India. Integrated Disease Surveillance Programme (IDSP) report on vector-borne diseases. 2021.
  6. Biswas S, Chattopadhyay S. Molecular characterization of dengue virus serotypes during the COVID-19 pandemic: Emerging challenges. Virol J. 2021;18(1):112.
  7. Premazzi Papa M, Mendoza-Torres E, Sun P, Encinales L, Goulet J, Defang G, et al. Dengue NS1 antibodies are associated with clearance of viral nonstructural protein-1. J Infect Dis. 2024;230(6):e1226–e1234. doi: 10.1093/infdis/jiae299.
  8. Huang CH, Lin YT, Wang SF. Co-detection of NS1 and IgM in dengue patients: Implications for diagnostic timing. J Clin Virol. 2021;145:104923.
  9. Almiron WR, Colombo VE, Estallo EL. Gender-specific exposure to Aedes aegypti mosquitoes: A meta-analysis of epidemiological studies in dengue-endemic regions. Trop Med Health. 2022;50(1):23.
  10. Li J. Outdoor exposure dynamics and dengue risk in urban youth: A longitudinal cohort study. Emerg Infect Dis. 2023;29(4):712–720.
  11. Stoddard ST. Dengue vector productivity in urban built environments: A meta-analysis of Aedes aegypti breeding patterns. Emerg Infect Dis. 2023;29(5):923–931.
  12. Lowe R. Combined effects of COVID-19 and dengue outbreaks: A modeling study. PLoS Negl Trop Dis. 2021;15(6):e0009435.
  13. Bowman LR. Community-based dengue prevention programs in Latin America: A systematic review of effectiveness and implementation factors. Am J Trop Med Hyg. 2022;106(3):845-854.
  14. Chakraborty T. Impact of COVID-19 on Dengue Epidemiology: A Review of Current Evidence and Future Implications. Trop Med Int Health. 2022;27(3):245-258.
  15. Colon-Gonzalez FJ. Delayed dengue epidemic patterns following monsoon rains in Southeast Asia. Nat Clim Chang. 2023;13(2):178–185.
  16. Potts JA. Immunoglobulin M as a predictor of clinical outcomes in dengue virus infection. J Infect Dis. 2021;224(12):2131–2139.
  17. Katzelnick LC, Ben-Shachar R, Koelle K. Dengue serotype interactions and population immunity dynamics: A modeling study. Sci Transl Med. 2023;15(684):eabq3511.
  18. Roy SK, Bhattacharjee S. Dengue virus: Epidemiology, biology and disease aetiology. Can J Microbiol. 2021 Oct;67(10):687-702.

Figures:

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?